Trimegah Bangun Persada Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Trimegah Bangun Persada Tbk. trades at Rp885 (market cap 54.26T, 56.47M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 314× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (56.47M versus 592.2K). Which is the better fit depends on your goals.
| NCKL | OBAT | |
|---|---|---|
Market Cap | 54.26T | 172.82B |
Volume | 56.47M | 592.2K |
Lot | 564.68K | 5.92K |
Turnover | 50.19B | 147.05M |
Average Price | 888.82 | 248.31 |
Value | 50.19B | 147.05M |
Indicative Equilibrium Price | 885 | 254 |
Indicative Equilibrium Volume | 11.61K | 10 |
Trailing returns across standard periods
Latest headlines on both assets
PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.
Read more on NCKL →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →